Yield10 Bioscience, Inc. (YTEN) Tops Q3 EPS by 16c

Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q3 EPS of ($0.49), $0.16 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $92 thousand versus the consensus estimate of $210 thousand.

For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65
• Integra Resources (ITRG) Tops Q2 EPS by 6c